Med-Tech Innovation January 2, 2024

EQT X fund has entered into an agreement to acquire Zeus from the Tourville family. Founded in 1966, Zeus is a specialist in the design, development, and extrusion of fluoropolymer tubing for medical devices and select industrial applications.

EQT also announced that John Groetelaars, former CEO of Hillrom and EQT industrial advisor, will serve as Zeus’ executive chairman upon closing of the transaction.

For more than 50 years, Zeus has delivered components to improve the efficacy and performance of catheters, which are used in minimally invasive medical procedures among other applications. The company is headquartered in Orangeburg, South Carolina, with eight facilities across the United States and one in Letterkenny,...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Medical Devices, Mergers & Acquisitions / JV, Trends
What tariffs mean for the medical device industry - and who will pay for them?
FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns
Labcorp to buy Opko unit’s cancer test assets for up to $225M
Qualcomm CEO: AI Is the New User Interface for Devices
FTC sues to block merger of device coatings companies

Share This Article